These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 23704278)

  • 21. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
    Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
    Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
    He D; Yue Z; Li G; Chen L; Feng H; Sun J
    Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
    Ling H; Pickard K; Ivan C; Isella C; Ikuo M; Mitter R; Spizzo R; Bullock M; Braicu C; Pileczki V; Vincent K; Pichler M; Stiegelbauer V; Hoefler G; Almeida MI; Hsiao A; Zhang X; Primrose J; Packham G; Liu K; Bojja K; Gafà R; Xiao L; Rossi S; Song JH; Vannini I; Fanini F; Kopetz S; Zweidler-McKay P; Wang X; Ionescu C; Irimie A; Fabbri M; Lanza G; Hamilton SR; Berindan-Neagoe I; Medico E; Mirnezami A; Calin GA; Nicoloso MS
    Gut; 2016 Jun; 65(6):977-989. PubMed ID: 25804630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
    Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
    Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
    Basati G; Razavi AE; Pakzad I; Malayeri FA
    Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
    Li G; Zhao D; Peng X; Zhao Y
    Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.
    Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X
    Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.